View in-depth coverage of the 2025 ASCO GU Symposium from GU oncology experts and key opinion leaders.
Conference Coverage
Coverage of the major medical conferences that impact genitourinary oncology professionals.
Advertisement
Advertisement
2024
2023
2022
GU Oncology Now delivers the latest genitourinary oncology conference coverage, highlighting advancements in treatments and tech.
Get exclusive conference news straight to your inbox.
Knowledge Hub Spotlights
Curated clinical content based on conditions, therapies, and technologies
Roundtables
Clinical discussions with experts in the field
The panel highlights key ASCO GU 2025 data, including TALAPRO-2, PSMA PET, the PORTOS score, and emerging therapies like EZH2
The panel discusses data from PEACE-3 and maintaining ARSI therapy with emerging combination treatments.
The experts discuss treatment selection in mHSPC and share insights from STOPCAP and ARANOTE on ARSI use in older patients.
The panel covers metastasis-directed therapy and trials including SWOG 1802 in oligometastatic prostate cancer.
The panelists examine biomarker adoption challenges and the impact of PSMA PET on staging and treatment decisions.
Experts discuss advances in biomarker testing, treatment intensification, and the impact of TALAPRO-2 in prostate cancer care